Zen Technologies Ltd Q4 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/3kh1k2pm89nma6fdfi9is7g6.pdf

Key Takeaways


The Revenue Miss & Working Capital Build

Ashok Atluri: "I have nothing to say but I may offer an unqualified apology. We shouldn't have fallen short but we made our best attempt but we couldn't reach."

FY25 Growth Ambition & Order Book Dynamics


Margin Profile & Cost Structure Reset

Ashok Atluri: "I really want to temper those expectations. Especially, given the vast product mix that we have and especially for highly commercial, dual use commercial simulators, we have the cost of production as a little higher than the regular ones."

Export Opportunity & Competitive Position

Ashok Atluri: "So keeping these two things, the preparedness and the emerging threat. Both the solutions are available with Zen Technologies, so we are at a very, very sweet spot and we expect a lot of inquiries as we are dealing, a lot of inquiries coming in, we can feel it and we think that there will be tremendous growth in the export area from both these fronts."

Product Pipeline & Strategic Investments

Ashok Atluri: "this cat and mouse game keeps going on, one upmanship keeps going on this"

Guidance & Commitments

CommitmentSpecificsTimeline
Revenue targetExceed ₹900 crores in standalone revenueFY25
Profitability35% EBITDA and 25% PAT marginsFY25
Export mixExports to contribute 30-35% of revenueFY25
Order inflow₹1,200 to ₹1,300 crores in new orders, from existing products onlyFY25 (majority in Q3/Q4)
Working capital cycleMaintain within 140 to 160 daysOngoing
Raw material costNormalize at 35% to 40% of revenueOngoing
R&D spendApproximately ₹30 crores, with opportunistic upsideFY25
FY27 revenue target₹2,000 crores, a 50% CAGR from FY25FY27

Key Metrics

MetricQ4 FY24
Revenue (standalone)₹430 cr, +167% YoY; fell short of ₹450 cr guidance by ~5%
Q4 FY24 revenue₹136 cr, up 167% YoY
EBITDA margin guidance35%, expected to be sustainable in FY25
PAT margin guidance25%, expected to be sustainable in FY25
Order book₹1,400+ cr as of 31st March, including ₹400+ cr for exports
Order wins (FY24)₹1,350 cr, a record year for order inflows
FY25 revenue target₹900+ cr, based on existing order book
FY27 revenue target₹2,000 cr, implying a 50% CAGR from FY25
Export contribution target~35% of revenue going forward
Working capital cycle148 days, expected to remain in the 140–160 day range
Receivable days143 days, driven by higher Q4 sales; absolute receivables at ₹169 cr
Inventory days113 days, inventory rose to ₹133 cr from ₹41 cr to support execution
Advance from customers146 days, included in other current liabilities
R&D spend (FY25 plan)~₹30 cr, opportunistic investments may increase this
Order inflow target (FY25)₹1,200–1,300 cr, expected to materialize from Q3 and Q4
High-probability order pipeline~₹900 cr, in addition to the existing order book
Raw material cost range (going forward)35%–40% of revenue, up from 25%–27% trend due to product mix and scale
Simulator EBITDA margin~40% on average
Anti-drone EBITDA margin~30% on average
Insurance claim received₹4.4 cr, against original claim of ₹6.56 cr; balance ₹2.16 cr written off earlier
QIP enabling resolutionUp to ₹1,000 cr, no target identified yet